Genitourinary Cancer
Commentary
Unleashing Our Immune Response to Quash Cancer
“It’s astounding how devious cancer cells and tumor tissue can be.”
News
Is MRI Screening Unnecessarily High in Prostate Cancer?
Expert emphasizes the necessity of observing a decrease in overall prostate cancer incidence before asserting that the current cancer diagnostics...
News
Focal Therapy for Prostate Cancer: Evidence-Based or Oversold?
Richard LaFrate’s urologist asked him to pay $25,000 out of pocket to undergo a focal procedure at a clinic in the Bahamas.
Latest News
Plant-Based Diet a Boon for Men With Prostate Cancer
A diet of fresh vegetables and fruit with few animal-based products is linked to reduced risk for recurrent prostate cancer, says study.
Latest News
Cardiorespiratory Fitness May Cut Prostate Cancer Risk
The association between change in absolute CRF and prostate cancer incidence was significant only for participants with a moderate baseline...
Conference Coverage
Small PFS gain in metastatic prostate cancer with TKI and ICI
Expert questions the choice of an androgen receptor pathway inhibitor (ARPI) switch as the control arm of the study.
Conference Coverage
Combo Tx Best in Metastatic Prostate Cancer with HRR Mutations
PFS was better with abiraterone/prednisone and olaparib vs. monotherapy in men with metastatic castration-resistant prostate cancer with DNA...
News
More Side Effects With Local Therapies for Prostate Cancer
What impact does local therapy have on the men’s quality of life?
Latest News
New Guidelines: Start PSA Screening Earlier in Black Men
Baseline PSA testing in Black men should begin at age 40-45, and should be followed by regular screening intervals, preferably annually.
Conference Coverage
Stockholm3 Prostate Test Bests PSA for Prostate Cancer Risk in North America
The Stockholm3 blood test, using a multiplex algorithm, shows benefits over PSA in a diverse, multi-ethnic cohort beyond a Swedish population...
